Centers for disease control and prevention sexually transmitted disease treatment guidelines

Clinical Infectious Diseases

Volumn 53, Issue SUPPL. 3, 2011, Pages

  Workowski, Kimberly A ^a,b   Berman, Stuart M ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; AZITHROMYCIN; BENZATHINE PENICILLIN; DOXYCYCLINE; ERYTHROMYCIN; GREEN TEA EXTRACT; HEPATITIS B VACCINE; IMIQUIMOD; METRONIDAZOLE; MOXIFLOXACIN; PENICILLIN G; TINIDAZOLE; WART VIRUS VACCINE;

ARTICLE; CHLAMYDIA TRACHOMATIS; CHLAMYDIASIS; CONDYLOMA ACUMINATUM; DISEASE TRANSMISSION; DRUG EFFICACY; GONORRHEA; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LESBIAN; MALE HOMOSEXUAL; MYCOPLASMA GENITALIUM; NEISSERIA GONORRHOEAE; NEWBORN OPHTHALMIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; SEXUALLY TRANSMITTED DISEASE; SINGLE DRUG DOSE; SYPHILIS; TRICHOMONAS VAGINALIS; TRICHOMONIASIS; URETHRITIS; VACCINATION; VITILIGO; WART VIRUS;

ADOLESCENT; ADULT; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; PRACTICE GUIDELINES AS TOPIC; SEXUALLY TRANSMITTED DISEASES; UNITED STATES; YOUNG ADULT;

EID: 81055144407     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir694     Document Type: Article

References (45)

1. Weinstock H, Berman S, Cates W. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health 2004; 36:6-10. (Pubitemid 38258322)
2. Centers for Disease Control and Prevention (CDC). Sexually transmitted diseases treatment guidelines 2010.MMWRRecomm Rep 2010; 59:1-116.
3. Centers for Disease Control and Prevention (CDC). Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007; 56:1-24.
4. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59:626-9.
5. Centers for Disease Control and Prevention (CDC). FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2010; 59:630-2.
6. Mast EE, Weinbaum CM, Fiore AE, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006; 55:1-33.
7. Ciesielski CA. Sexually transmitted diseases in men who have sex with men: an epidemiologic review. Curr Infect Dis Rep 2003; 5:145-52. (Pubitemid 38899171)
8. Van der Bij AK, Spaargaren J, Morre SA, et al. Diagnostic and clinical implications of anorectal lymphogranuloma venereum in men who have sex with men: a retrospective case-control study. Clin Infect Dis 2006; 42:186-94. (Pubitemid 43054189)
9. Sethi G, Allason-Jones E, Richens J, et al. Lymphogranuloma venereum presenting as genital ulceration and inguinal syndrome in men who have sex with men in London, United Kingdom. Sex Transm Infect 2009; 85:165-70.
10. Urbanus AT, van de Laar TJ, Stole IG, et al. Hepatitis C virus infections among HIV-infectedmen who have sex with men. AIDS 2009; 23:F1-F7.
11. Danta M, Brown D, Bhagani S, et al. Recent epidemic of acute hepatitis C virus in HIV-positive men who sex with men linked to high-risk sexual behaviors. AIDS 2007; 21:983-91. (Pubitemid 46684329)
12. Singh D, Fine DN, Marrazzo JM. Chlamydia trachomatis infection among women reporting sexual activity with women screened in family planning clinics in the Pacific Northwest, 1997 to 2005. Am J Public Health 2011; 101:1784-90.
13. Fethers KA, Fairley CK, Hocking JS, Gurrin LC, Bradshaw CS. Sexual risk factors and bacterial vaginosis: a systematic review and metaanalysis. Clin Infect Dis 2008; 47:1426-35.
14. Marrazzo JM, Thomas KK, Agnew K, Ringwood K. Prevalence and risks for bacterial vaginosis in women who have sex with women. Sex Transm Dis 2010; 37:335-9.
15. Centers for Disease Control and Prevention (CDC). Sexually transmitted disease surveillance, 2009. Atlanta, GA: US Department of Health and Human Services, 2010.
16. Schachter J, Moncada J, Liska S, Shayevich C, Klausner JD. Nucleic acid amplification tests in the diagnosis of chlamydial and gonococcal infections of the oropharynx and rectum in men who have sex with men. Sex Transm Dis 2008; 35:637-42.
17. Geisler WM, Wang C, Morrison SG, et al. The natural history of untreated Chlamydia trachomatis infection in the interval between screening and returning for treatment. Sex Transm Dis 2008; 35:119-23. (Pubitemid 351158688)
18. Fung M, Scott KC, Kent CK, et al. Chlamydial and gonococcal reinfection among men: a systematic review of data to evaluate the need for retesting. Sex Transm Infect 2007; 83:304-9. (Pubitemid 47242509)
19. Hosenfeld CB, Workowski KA, Berman S, et al. Repeat infection with chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 2009; 36:478-89.
20. Giradet RG, McClain N, Lahoti S, Cheung K, Hartwell B, McNeese M. Comparison of the urine-based ligase chain reaction test to culture for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in pediatric sexual abuse victims. Pediatr Infect Dis J 2000; 20:144-7. (Pubitemid 32151935)
21. Centers for Disease Control and Prevention (CDC). Guidelines for the laboratory diagnosis of gonorrhea, chlamydia and syphilis. Available at: http://www.aphl.org/aphlprograms/infectious/std/Pages/stdtestingguidelines.aspx. Accessed 17 May 2011.
22. Black CM, Driebe EM, Howard LA, et al. Multicenter study of nucleic acid amplification tests for detection of Chlamydia trachomatis and Neisseria gonorrhoeae in children being evaluated for sexual abuse. Pediatr Infect Dis J 2009; 28:608-13.
23. Fleming DT, Wasserheit JN. From epidemiologic synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Trans Infect 1999; 75:3-17. (Pubitemid 29117474)
24. Rolfs RT, Joesoef MR, Hendershot EF, et al. A randomized trial of enhanced therapy for early syphilis in patients with and without human immunodeficiency virus infection: the Syphilis and HIV Study Group. N Engl J Med 1997; 337:307-14. (Pubitemid 27318992)
25. Hook EW 3rd, Martin DH, Stephens J, Smith BS, Smith K. A randomized, comparative pilot study of azithromycin versus benzathine penicillin G for treatment of early syphilis. Sex Transm Dis 2002; 29: 486-90. (Pubitemid 34851786)
26. Riedner G, Rusizoka M, Todd J, et al. Single-dose azithromycin versus penicillin G benzathine for the treatment of early syphilis. N Engl JMed 2005; 353:1236-44. (Pubitemid 41345945)
27. Hook EW 3rd, Behets F, Van Damme K, et al. A phase III equivalence trial of azithromycin versus benzathine penicillin for treatment of early syphilis. J Infect Dis 2010; 201:1729-35.
28. Lukehart SA, Godornes C, Molini BJ, et al. Macrolide resistance in Treponema pallidum in the United States and Ireland. N Engl J Med 2004; 351:154-8.
29. Marra CM, Maxwell CL, Smith SL, et al. Cerebrospinal fluid abnormalities in patients with syphilis: association with clinical and laboratory features. J Infect Dis 2004; 189:369-76. (Pubitemid 38210572)
30. Marra CM, Maxwell CL, Tantalo LC, Sahi SK, Lukehart SA. Normalization of serum rapid plasma reagin titer predicts normalization of cerebrospinal fluid and clinical abnormalities after treatment of neurosyphilis. Clin Infect Dis 2008; 47:893-9.
31. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Neurosyphilis in a clinical cohort of HIV-1-infected patients. AIDS 2008; 22:1145-51.
32. Ghanem KG, Moore RD, Rompalo AM, Erbelding EJ, Zenilman JM, Gebo KA. Antiretroviral therapy is associated with reduced serologic failure rates for syphilis among HIV-infected patients. Clin Infect Dis 2008; 47:258-65. (Pubitemid 351920630)
33. Mena LA, Mroczkowski TF, Malanda N, Martin DH. A randomized comparison of azithromycin and doxycycline for the treatment of Mycoplasma genitalium-positive urethritis in men. Clin Infect Dis 2009; 48:1649-54.
34. Bradshaw CS, Chen MY, Fairley CK. Persistence of Mycoplasma genitalium following azithromycin therapy. PLoS One 2008; 3:e3618.
35. Jernberg E, Moghaddam A, Moi H. Azithromycin and moxifloxacin for microbiological cure of Mycoplasma genitalium infection: an open study. Int J STD AIDS 2008; 19:676-9.
36. Ho GY, Burk RD, Klein S, et al. Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia. J Natl Cancer Inst 1995; 87:1365-71.
37. Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14:467-75. (Pubitemid 40270113)
38. Mashiah J, Brenner S. Possible mechanisms in the induction of vitiligolike hypopigmentation by topical imiquimod. Clin Exp Dermatol 2008; 33:74-6. (Pubitemid 350308512)
39. Forna F, Gulmezoglu AM. Interventions for treating trichomoniasis in women. Cochrane Database Syst Rev 2003; (2);CD000218.
40. Crowell AL, Sanders-Lewis KA, Secor WE. In vitro metronidazole and tinidazole activities against metronidazole-resistant strains of Trichomonas vaginalis. Antimicrob Agents Chemother 2003; 47:1407-9. (Pubitemid 36368606)
41. Sobel JD, Nyirjesy P, Brown W. Tinidazole therapy for metronidazoleresistant vaginal trichomoniasis. Clin Infect Dis 2001; 33:1341-6. (Pubitemid 32955184)
42. Bosserman EA, Helms DJ, Mosure DJ, Secor WE, Workowski KA. Utility of antimicrobial susceptibility testing in Trichomonas vaginalis infected women with clinical treatment failure. Sex Transm Dis 2011; 38:1-5.
43. Kissinger P, Mena L, Levison J, et al. A randomized treatment trial: single versus 7 day dose of metroidazole for the treatment of Trichomonas vaginalis among HIV-infected women. J Acquir Immune Defic Syndr 2010; 55:565-71.
44. Peterman TA, Tian LH, Metcalf CA, et al. High incidence of new sexually transmitted infections in the year following a sexually transmitted infection: a case for rescreening. Ann Intern Med 2006; 145: 564-72. (Pubitemid 46780935)
45. Kissinger P, Secor WE, Leichliter JS, et al. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women. Clin Infect Dis 2008; 46:994-9. (Pubitemid 351589863)